nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.07.2012 | Article

Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency

verfasst von: J. H. Boone, M. Goodykoontz, S. J. Rhodes, K. Price, J. Smith, K. N. Gearhart, R. J. Carman, T. M. Kerkering, T. D. Wilkins, D. M. Lyerly

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

We evaluated Clostridium difficile prevalence rates in 2,807 clinically indicated stool specimens stratified by inpatient (IP), nursing home patient (NH), outpatient (OP), age, gender, and specimen consistency using bacterial culture, toxin detection, and polymerase chain reaction (PCR) ribotyping. Rates were determined based on the detection of toxigenic C. difficile isolates. We identified significant differences in the rates between patient populations and with age. Specimens from NH had a higher rate (46%) for toxigenic C. difficile than specimens from IP (18%) and OP (17%). There were no gender-related differences in the rates. Liquid specimens had a lower rate (15%) than partially formed and soft specimens (25%) and formed specimens (18%) for the isolation of toxigenic C. difficile. The nontoxigenic rate was lowest for NH (4%) and highest for patients <20 years of age (23%). We identified 31 different toxigenic ribotypes from a sampling of 190 isolates that showed the lowest diversity in NH. Fluoroquinolone resistance was observed in 93% of the 027 isolates, all of the 053 isolates, and in four other ribotypes. We observed different rates for toxigenic C. difficile in stratified patient populations, with the highest rate for NH, a low overall nontoxigenic rate, and fluoroquinolone resistance.

Bartlett JG (1995) Antibiotic-associated diarrhea. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL (eds) Infections of the gastrointestinal tract. Raven Press, Ltd., New York

Surawicz CM, McFarland LV (1999) Pseudomembranous colitis: causes and cures. Digestion 60:91–100PubMedCrossRef

Bartlett JG (2007) Clostridium difficile: old and new observations. J Clin Gastroenterol 41(Suppl 1):S24–S29CrossRef

Kyne L, Hamel MB, Polavaram R, Kelly CP (2002) Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34:346–353PubMedCrossRef

Hull MW, Beck PL (2004) Clostridium difficile-associated colitis. Can Fam Physician 50:1536–1545PubMed

Otten AM, Reid-Smith RJ, Fazil A, Weese JS (2010) Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect 138(6):907–914PubMedCrossRef

Muto CA (2007) Asymptomatic Clostridium difficile colonization: is this the tip of another iceberg? Clin Infect Dis 45:999–1000PubMedCrossRef

Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45:992–998PubMedCrossRef

Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S et al (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442–2449PubMedCrossRef

10.

McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP et al (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353:2433–2441PubMedCrossRef

11.

McEllistrem MC, Carman RJ, Gerding DN, Genheimer CW, Zheng L (2005) A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 40:265–272PubMedCrossRef

12.

Pépin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173(9):1037–1042. doi:10.1503/cmaj.050978 PubMedCrossRef

13.

Hubert B, Loo VG, Bourgault A-M, Poirier L, Dascal A, Fortin E et al (2007) A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. Clin Infect Dis 44(2):238–244PubMedCrossRef

14.

O’Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136:1913–1924PubMedCrossRef

15.

Carman RJ, Genheimer CW, Rafii F, Park M, Hiltonsmith MF, Lyerly DM (2009) Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. Anaerobe 15:244–248PubMedCrossRef

16.

Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D (2004) Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies. CMAJ 171:33–38PubMedCrossRef

17.

Dial S, Delaney JA, Barkun AN, Suissa S (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294:2989–2995PubMedCrossRef

18.

Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, Allison MC (2006) Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther 24:613–619PubMedCrossRef

19.

Wultańska D, Banaszkiewicz A, Radzikowski A, Obuch-Woszczatyński P, Młynarczyk G, Brazier JS et al (2010) Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. Eur J Clin Microbiol Infect Dis 29(10):1265–1270. doi:10.1007/s10096-010-0997-9 PubMedCrossRef

20.

Clayton EM, Rea MC, Shanahan F, Quigley EM, Kiely B, Hill C et al (2009) The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 104:1162–1169PubMedCrossRef

21.

Huebner ES, Surawicz CM (2007) Clostridium difficile in relapse of inflammatory bowel disease. In: Katz S (ed) Inflammatory bowel disease: a practical approach, series #27. Practical Gastroenterology, January 2007, pp 42–47

22.

Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD (2007) Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 5:339–344PubMedCrossRef

23.

Tremaine WJ (2007) Inflammatory bowel disease and Clostridium difficile-associated diarrhea: a growing problem. Clin Gastroenterol Hepatol 5:310–311PubMedCrossRef

24.

Issa M, Ananthakrishnan AN, Binion DG (2008) Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 14:1432–1442PubMedCrossRef

25.

Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32(9):920–924PubMedCrossRef

26.

Katz DA, Lynch ME, Littenberg B (1996) Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 100(5):487–495PubMedCrossRef

27.

Lin YC, Huang YT, Tsai PJ, Lee TF, Lee NY, Liao CH et al (2011) Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in Taiwan. Antimicrob Agents Chemother 55(4):1701–1705PubMedCrossRef

28.

Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B et al (2010) The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23:529–549PubMedCrossRef

29.

Rudensky B, Rosner S, Sonnenblick M, van Dijk Y, Shapira E, Isaacsohn M (1993) The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalized patients. Postgrad Med J 69(807):45–47PubMedCrossRef

30.

Wilkins TD, Lyerly DM (2003) Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 41:531–534PubMedCrossRef

31.

Goldstein EJ, Polonsky J, Touzani M, Citron DM (2009) C. difficile infection (CDI) in a long-term acute care facility (LTAC). Anaerobe 15:241–243PubMedCrossRef

32.

Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC et al (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31:431–455PubMedCrossRef

33.

Kvach EJ, Ferguson D, Riska PF, Landry ML (2010) Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 48:109–114PubMedCrossRef

34.

Goorhuis A, Debast SB, Dutilh JC, van Kinschot CM, Harmanus C, Cannegieter SC et al (2011) Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 53(9):860–869, Epub 2011 Sep 13PubMedCrossRef

Titel: Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency
verfasst von: J. H. Boone
M. Goodykoontz
S. J. Rhodes
K. Price
J. Smith
K. N. Gearhart
R. J. Carman
T. M. Kerkering
T. D. Wilkins
D. M. Lyerly
Publikationsdatum: 01.07.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-011-1477-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2012

Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000–2009

Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy

Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it

Impact of rhinoviruses on pediatric community-acquired pneumonia

The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience